Patients with symptomatic, recurrent AVNRT require a structured, guideline-aligned approach. This page summarises the clinical scenario and points to the complete evidence-based protocol.
The protocol targets patients with symptomatic, recurrent atrioventricular nodal re-entrant tachycardia — those experiencing repeated, clinically significant episodes. Catheter ablation is the recommended intervention for this presentation.
When catheter ablation is not desirable or feasible, pharmacological management with certain rate-controlling drug classes may be considered — with agent selection guided by the individual patient's cardiac function. The full protocol specifies the options, selection criteria, and clinical decision points.
DOI: 10.1093/eurheartj/ehz467
Catheter ablation is recommended for symptomatic, recurrent AVNRT.
Diltiazem or verapamil, in patients without HFrEF, or beta-blockers should be considered if ablation is not desirable or feasible.
View source ↗